Movement disorders in hereditary spastic paraplegias. [PDF]
Arq Neuropsiquiatr, 2023 Pedroso JL +9 more
europepmc +1 more source
Transient benign paroxysmal movement disorders in infancy. [PDF]
Rev Neurol, 2022 Mosca S, Martins J, Temudo T.
europepmc +1 more source
[Neurocovid-19: effects of COVID-19 on the brainNeurocovid-19: efeitos da COVID-19 no cérebro]. [PDF]
Rev Panam Salud Publica, 2022 Matar-Khalil S.
europepmc +1 more source
Aplicações não cosméticas da toxina botulínica em dermatologia
, 2015 Trabalho final de mestrado integrado em Medicina, apresentado à Faculdade de Medicina da Universidade de Coimbra.As indicações terapêuticas da toxina botulínica (BTX) expandiram-se consideravelmente desde a primeira utilização com esta finalidade, há ...
Soares, Carolina Lourenço
core
The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use. [PDF]
Neurocrit Care, 2020 McNett M +16 more
europepmc +1 more source
Thiamine transporter-2 deficiency: outcome and treatment monitoring. [PDF]
Orphanet J Rare Dis, 2014 Ortigoza-Escobar JD +8 more
europepmc +1 more source
Laryngoscopy evaluation protocol for the differentiation of essential and dystonic voice tremor. [PDF]
Braz J Otorhinolaryngol, 2016 Moraes BT, Biase NG.
europepmc +1 more source
Botulinum toxin treatment in a resource-limited setting: Experiences from a public institution in a developing country [PDF]
BiomedicaPanesso GA +7 more
europepmc +1 more source
Effects of onabotulinum toxin type A injections in patients with Meige's syndrome. [PDF]
Arq NeuropsiquiatrDuarte A +3 more
europepmc +1 more source